Coloplast A/S logo

Coloplast A/S

COLO-B.CO
HealthcareCPHDenmark
432.50DKK+11.80 (+2.80%)

About Coloplast

Coloplast A/S develops and markets healthcare products and services for intimate and chronic conditions across Denmark, the U.S., the U.K., France, and internationally.

The company operates through four segments:

  • Chronic Care:

    • Ostomy Care: SenSura Mio (custom fit and discretion), SenSura, and accessories under the Brava brand

    • Continence Care: Conveen Active urine bags, SpeediCath catheters (for men and women), and Peristeen transanal irrigation system

  • Wound & Skin Care:

    • Wound Care: Biatain Silicone (conforming dressing), Comfeel (hydrocolloid dressing)

    • Skin Care: Cleansers, moisturizers, antifungal treatments, skin protectants, odor control, hand cleansers, and InterDry (skin fold management)

  • Interventional Urology:

    • Solutions for urinary stone disease, benign prostatic hyperplasia, erectile dysfunction, urinary incontinence, and voiding dysfunctions
  • Voice and Respiratory Care:

    • Voice Products: Provox devices for neck stoma

    • Respiratory Products: TRACOE devices for tracheostoma care

Founded in 1954, Coloplast is headquartered in Humlebæk, Denmark.

Coloplast's Business Strategy

Coloplast operates with a specialized focus on intimate healthcare needs, developing products and services for individuals with deeply personal medical conditions across four key segments: Ostomy Care, Continence Care, Advanced Wound Care, and Interventional Urology. This concentrated approach has established Coloplast as a global leader…

Available on Finplify

Free account required

Sign up free

Our Take on Coloplast

Pros:

Aging & Chronic Illness Rising Demand: An aging population and growing cases of bowel disease are driving steady demand for Coloplast’s products.

Recurring Revenue from Consumables: Most of Coloplast’s portfolio consists of single-use medical devices used daily by patients ( catheters, ostomy bags).…

Available on Finplify

Free account required

Sign up free

Company Details

Exchange
CPH
Country
Denmark
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Lars Soren Rasmussen
Employees
16,741
IPO Date
2000-01-02
ISIN
DK0060448595
Website
coloplast.com

Key Metrics

Market Cap
97.47BDKK
P/E Ratio (TTM)
23.73
Net Profit Margin
14.30%
Debt / Asset Ratio
0.53
Dividend Yield (TTM)
5.47%
Volume
129,584
Avg Volume
312,089
Shares Outstanding
225.37M
Free Float
63.66%
β Beta
0.59
52W Range
418.3 - 748.0

Fundamental Analysis

Proprietary 5-category scoring system

Score Fingerprint

Section Scores

Profitability
4.3/5Excellent
Liquidity
2.9/5Average
Leverage
2.0/5Weak
Cash Flow
4.5/5Excellent
Valuation
3.9/5Good

Full Breakdown & Peer Ranking

See the detailed score for every metric and how this stock ranks against its sector peers

Unlock for free
Free to join

Unlock the full research on Coloplast

Get the full fundamental score breakdown, business strategy, our investment take, live charts and AI-powered briefings. All in one ad-free workspace.

300+ Curated Stocks

A hand-picked universe of world-class businesses across every major market and sector.

AI Analyst Briefings

Deploy your own AI analyst that monitors your portfolio and delivers daily intelligence reports.

Proprietary Fundamentals

Five-category scoring for every stock — profitability, liquidity, leverage, cash flow, and valuation.